KOTRA - stock earnings
0002.KL Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 11.6 million MYR | 57.5 million MYR |
| 2023Q3 | 13.7 million MYR | 53.3 million MYR |
| 2023Q2 | 13.1 million MYR | 55.8 million MYR |
| 2023Q1 | 17.5 million MYR | 59.4 million MYR |
| 2022Q4 | 16.4 million MYR | 62.3 million MYR |
| 2022Q3 | 18.2 million MYR | 64.8 million MYR |
| 2022Q2 | 16.2 million MYR | 48.8 million MYR |
| 2022Q1 | 17.0 million MYR | 55.2 million MYR |
| 2021Q4 | 13.9 million MYR | 52.8 million MYR |
| 2021Q3 | 14.9 million MYR | 51.1 million MYR |
| 2021Q2 | 12.4 million MYR | 43.5 million MYR |
| 2021Q1 | 6.2 million MYR | 43.3 million MYR |
| 2020Q4 | 3.2 million MYR | 38.2 million MYR |
| 2020Q3 | 2.5 million MYR | 34.6 million MYR |
| 2020Q2 | 7.9 million MYR | 36.8 million MYR |
| 2020Q1 | 7.6 million MYR | 46.5 million MYR |
| 2019Q4 | 8.9 million MYR | 48.9 million MYR |
| 2019Q3 | 5.1 million MYR | 39.6 million MYR |
| 2019Q2 | 6.5 million MYR | 39.8 million MYR |
| 2019Q1 | 5.2 million MYR | 40.7 million MYR |
0002.KL Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 60.7 million MYR | 230.8 million MYR |
| 2022 | 65.2 million MYR | 242.2 million MYR |
| 2021 | 62.1 million MYR | 207.9 million MYR |
| 2020 | 24.4 million MYR | 159.6 million MYR |
| 2019 | 29.6 million MYR | 171.7 million MYR |
| 2018 | 22.2 million MYR | 172.6 million MYR |
| 2017 | 15.7 million MYR | 178.5 million MYR |
| 2016 | 12.4 million MYR | 166.4 million MYR |
| 2015 | 7.8 million MYR | 160.2 million MYR |
| 2014 | 1.1 million MYR | 145.2 million MYR |
0002.KL
Price: MYR4.68
Dividend Yield: 5.27%
Forward Dividend Yield: 5.34%
Payout Ratio: 65.79%
Dividend Per Share: 0.25 MYR
Earnings Per Share: 0.38 MYR
P/E Ratio: 12.50
Exchange: KLS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 704.5 million
Average Dividend Frequency: 2
Years Paying Dividends: 8
DGR3: 30.00%
DGR5: 30.00%